RedHill Biopharma CEO In Interview With Benzinga Says Co. Can't Launch BEKINDA In Gastroenteritis Alone, Will Need To Co-Promote With Partner Or License Outright; Says Co. Has No Plans 'For any immediate or short-term financing from the financial markets'